Position in LLY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$34,689,912
+$7,171,317 QoQ
Shares Held
28,922
-3.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.86%
of 13F equity value
Holder Rank
#657
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MEEDER ASSET MANAGEMENT INC holds $140,500,918 across 9 Drug Manufacturers - General names. LLY ranks #1 (24.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
28,922 | $34,689,912 | |
| 2 | JNJ |
Johnson & Johnson
|
117,192 | $29,763,248 | |
| 3 | ABBV |
AbbVie Inc.
|
98,512 | $24,789,557 | |
| 4 | AMGN |
Amgen Inc
|
65,451 | $23,701,113 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
135,547 | $17,125,003 | |
| 6 | MRK |
Merck & Co., Inc.
|
71,755 | $9,220,516 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
20,426 | $1,176,942 | |
| 8 | PFE |
Pfizer Inc
|
1,115 | $26,849 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,689,912 | 28,922 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $27,518,595 | 29,919 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $30,356,483 | 28,247 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $13,221,264 | 17,328 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $16,549,418 | 21,230 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $19,189,189 | 23,234 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $24,157,424 | 31,292 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $33,299,823 | 37,587 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $29,352,419 | 32,420 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $18,721,606 | 24,065 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $5,337,215 | 9,156 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $13,584,554 | 25,291 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $13,637,937 | 29,080 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $4,744,342 | 13,815 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $10,977,391 | 30,006 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $12,558,587 | 38,839 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,580,769 | 38,802 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $9,963,382 | 34,792 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $7,016,538 | 25,402 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $8,062,716 | 34,896 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $8,382,988 | 36,524 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $6,868,246 | 36,764 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $715,881 | 4,240 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $7,134,411 | 48,199 | Shares | Defined | 2020-11-02 | |
| 2020-06-30 | $9,932,557 | 60,498 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $9,217,939 | 66,450 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||